Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.450
+0.020 (1.40%)
At close: Feb 21, 2025, 4:00 PM
1.451
+0.001 (0.08%)
After-hours: Feb 21, 2025, 5:30 PM EST
Lexaria Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 |
| Market Capitalization | 25 | 62 | 8 | 18 | 35 | 31 | |
| Market Cap Growth | 135.49% | 627.66% | -51.77% | -50.18% | 13.53% | -42.60% | |
| Enterprise Value | 17 | 53 | 5 | 10 | 27 | 29 | |
| Last Close Price | 1.45 | 3.91 | 1.05 | 2.96 | 6.22 | 10.38 | |
| PS Ratio | 41.69 | 133.15 | 37.56 | 68.97 | 48.92 | 98.93 | |
| PB Ratio | 2.59 | 8.07 | 3.17 | 2.31 | 2.71 | 12.55 | |
| P/TBV Ratio | 3.92 | 8.22 | 3.29 | 2.36 | 2.74 | 13.95 | |
| EV/Sales Ratio | 35.14 | 114.33 | 21.58 | 39.44 | 37.19 | 92.55 | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.06 | 0.01 | 0.01 | 0.06 | |
| Asset Turnover | 0.07 | 0.08 | 0.04 | 0.02 | 0.09 | 0.11 | |
| Inventory Turnover | - | - | - | 2.11 | 2.39 | 0.81 | |
| Quick Ratio | 28.15 | 6.10 | 5.99 | 32.79 | 78.90 | 7.20 | |
| Current Ratio | 29.64 | 7.18 | 8.03 | 35.96 | 81.18 | 8.53 | |
| Return on Equity (ROE) | -114.83% | -112.36% | -130.18% | -71.35% | -73.16% | -166.85% | |
| Return on Assets (ROA) | -67.50% | -59.57% | -73.59% | -39.21% | -44.17% | -94.23% | |
| Return on Capital (ROIC) | -69.40% | -66.91% | -76.32% | -39.70% | -44.99% | -101.11% | |
| Earnings Yield | -28.76% | -9.37% | -78.45% | -41.27% | -11.39% | -12.63% | |
| FCF Yield | -25.82% | -8.09% | -69.63% | -27.98% | -11.28% | -8.41% | |
| Buyback Yield / Dilution | -93.37% | -87.24% | -12.38% | -34.02% | -58.34% | -6.95% | |
| Total Shareholder Return | -93.37% | -87.24% | -12.38% | -34.02% | -58.34% | -6.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.